EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Skin cancer risk in more than 200 000 patients with haematological malignancies over 30 years: a nationwide population-based study in the Netherlands

Celeste J Eggermont iD, Andrya Hollatz iD, Marlies Wakkee iD, Marieke Louwman iD, Avinash G Dinmohamed iD, Eduardus F M Posthuma iD, Tamar Nijsten iD, Loes Hollestein iD

British Journal of Dermatology · 19.05.2025 · 192 (6) · 1029-1037

DOI: 10.1093/bjd/ljaf027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 24.01.2025. Verfasst von Celeste J Eggermont und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Skin Neoplasms, Hematologic Neoplasms, Melanoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with haematological malignancies are at increased risk of developing skin cancer and often experience worse skin cancer-related outcomes. However, there is a lack of nationwide, population-based data with long-term follow-up on the incidence and risks of different skin cancer types across all haematological malignancies.

Objectives

To assess population-based risk estimates for cutaneous squamous cell carcinoma (cSCC), malignant melanoma (MM), Merkel cell carcinoma (MCC) and basal cell carcinoma (BCC) among patients with haematological malignancies, stratified by skin cancer type and haematological malignancy subgroup. These estimates can serve as a base for surveillance guidelines and patient education.

Methods

This nationwide population-based epidemiological cohort study used data from 210 794 patients diagnosed with a haematological malignancy between 1989 and 2020 from the Netherlands Cancer Registry (NCR). In addition, data on each type of histopathologically confirmed skin cancer per patient after haematological malignancy diagnosis were retrieved from the NCR. Patients with a history of skin cancer prior to their haematological malignancy were excluded. Cumulative incidences, standardized incidence ratios (SIRs) and absolute excess risks for each of the four skin cancers were calculated and stratified by haematological malignancy subgroup, age, sex, follow-up and primary treatment.

Results

The overall 10-year cumulative incidence of developing a first skin cancer was 2.6% for cSCC, 0.5% for MM, 0.05% for MCC and 4.8% for BCC. Compared with the general population, nearly all haematological malignancy subgroups showed more than a twofold increased risk of cSCC, MM, MCC and BCC. Patients with chronic lymphocytic leukaemia (CLL) showed the highest risks for each of the four skin cancers, with SIRs of 4.4 for cSCC, 2.7 for MM, 9.3 for MCC, and 2.6 for BCC. These elevated risks persisted for > 30 years after haematological malignancy diagnosis.

Conclusions

Patients with all types of haematological malignancies, and especially those with CLL, have a lifetime increased risk of developing different types of skin cancer. These findings highlight the importance of creating awareness among patients and care providers about this increased risk and promoting sun-protective measures and regular skin self-examinations in this high-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsHematologic NeoplasmsMelanomaCarcinoma, Squamous CellHumansNetherlandsMaleFemaleIncidenceMiddle AgedAgedAdultAged, 80 and overBasal Cell CarcinomaRegistriesYoung AdultRisk FactorsCarcinoma, Merkel CellAdolescentRisk Assessment

Autor:innen und Institutionen

  • Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.
  • Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
  • Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
  • Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Department of Internal Medicine, Reinier de Graaf Hospital, Delft, the Netherlands.
  • Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.

ORCID-Profile: Celeste J Eggermont, Andrya Hollatz, Marlies Wakkee, Marieke Louwman, Avinash G Dinmohamed, Eduardus F M Posthuma, Tamar Nijsten, Loes Hollestein

Zitieren

APA

Eggermont, C. J., Hollatz, A., Wakkee, M., Louwman, M., Dinmohamed, A. G., Posthuma, E. F. M., Nijsten, T., & Hollestein, L. (2025). Skin cancer risk in more than 200 000 patients with haematological malignancies over 30 years: a nationwide population-based study in the Netherlands. British Journal of Dermatology, 192(6), 1029-1037. https://doi.org/10.1093/bjd/ljaf027

Vancouver

Eggermont CJ, Hollatz A, Wakkee M, Louwman M, Dinmohamed AG, Posthuma EFM, et al. Skin cancer risk in more than 200 000 patients with haematological malignancies over 30 years: a nationwide population-based study in the Netherlands. British Journal of Dermatology. 2025;192(6):1029-1037. doi:10.1093/bjd/ljaf027

BibTeX
@article{Eggermont2025,
  author = {Eggermont, Celeste J and Hollatz, Andrya and Wakkee, Marlies and Louwman, Marieke and Dinmohamed, Avinash G and Posthuma, Eduardus F M and Nijsten, Tamar and Hollestein, Loes},
  title = {Skin cancer risk in more than 200 000 patients with haematological malignancies over 30 years: a nationwide population-based study in the Netherlands},
  journal = {British Journal of Dermatology},
  year = {2025},
  volume = {192},
  number = {6},
  pages = {1029--1037},
  doi = {10.1093/bjd/ljaf027}
}
Kostenlos starten →